Intestinal Polyposis: Clinical Trials

3 trials for Intestinal Polyposis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow Intestinal Polyposis: new trials by email Literature Review of Intestinal Polyposis trials Research Report on Intestinal Polyposis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Eflornithine, Eflornithine Placebo, Sulindac 150 MG - Familial Adenomatous Polyposis
Phase 3CompletedCancer Prevention Pharmaceuticals, Inc.1712013-10-012021-06-08
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
Celecoxib, Ursodeoxycholic acid, Placebo - Familial Adenomatous Polyposis, Duodenal Neoplasms
Phase 2 / Phase 3CompletedRadboud University Medical Center372009-05-012013-05-16
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
Eicosapentanoic Acid (EPA), Endoscopy, Biopsies taken - Familial Adenomatous Polyposis Coli, FAP
Phase 2 / Phase 3CompletedS.L.A. Pharma AG582006-11-012014-08-22

Narrower conditions

Adenomatous Polyposis Coli (3)  ·  Polyps (2)  ·  Adenoma (1)  ·  Adenomatous Polyps (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Duodenal Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Hyperplasia (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Neoplastic Syndromes, Hereditary (1)

Broader conditions

Colonic Diseases (3)  ·  Colorectal Neoplasms (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Adenoma (2)  ·  Adenomatous Polyps (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Genetic Diseases, Inborn (2)

Interventions

Celecoxib (1)  ·  Eflornithine (1)  ·  Eicosapentaenoic Acid (1)  ·  Endoscopy (1)  ·  Sulindac (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

Cancer Prevention Pharmaceuticals, Inc. (1)  ·  Radboud University Medical Center (1)  ·  S.L.A. Pharma AG (1)

Countries

Netherlands (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Bjorn WH van Heumen, MD (1)  ·  Carol Burke, M.D. (1)  ·  Ellen Kampman, Ph D (1)  ·  Fokko M Nagengast, MD, Ph D (1)  ·  James Church, M.D. (1)  ·  Nicholas J West, MB BS FRCS (1)  ·  Wilbert HM Peters, Ph D (1)

Results publications

PMID 20348368, PMID 23919274, PMID 24245549, PMID 32905675, PMID 34261858